Latin, English, French, Spanish:
Recommended INN

Chemical name or description; Molecular formula; Graphic formula

DCI Recommandée

Nom chimique ou description; Formule brute; Formule développée

DCI Recomendada

Nombre químico o descripción; Fórmula empírica; Fórmula desarrollada

acidum arundicum

arundic acid

(2R)-2-propyloctanoic acid

acide arundique

(-)-acide (2R)-2-propyloctanoïque

ácido arúndico

ácido (2R)-2-propiloctanoico

C₁₁H₂₂O₂

acidum salcaprozicum

salcaprozic acid

8-(2-hydroxybenzamido)octanoic acid

acide salcaprozique

acide 8-[(2-hydroxybenzoyl)amino]octanoïque

ácido salcaprózico

ácido 8-(2-hidroxibenzamido]octanoico

C₁₅H₂₁NO₄

alvocidibum

alvocidib

(-)-2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3R*,4S*)-3-hydroxy-1-methyl-4-piperidyl]-4H-chromen-4-one

alvocidib

(-)-2-(2-chlorophényl)-5,7-dihydroxy-8-[(3R*,4S*)-3-hydroxy-1-méthylpipéridin-4-yl]-4H-1-benzopyran-4-one

alvocidib

(-)-2-(2-clorofenil)-5,7-dihidroxi-8-[(3R*,4S*)-3-hidroxi-1-metilpiperidin-4-il]-4H-cromen-4-ona

C₂₁H₂₀ClNO₅

anatibantum

anatibant

(2S)-N-[3-(4-carbamimidoylbenzamido)propyl]-1-{2,4-dichloro-3-[(2,4-dimethyl-8-quinolyloxy)methyl]phenylsulfonyl}pyrrolidine-2-carboxamide

anatibant

(2S)-N-[3-[(4-carbamimidoylbenzoyl)amino]propyl]-1-[[2,4-dichloro-3-[[(2,4-diméthylquinoléin-8-yl)oxy]méthyl]phényl]sulfonyl]pyrrolidine-2-carboxamide

anatibant

(2S)-N-{3-[(4-carbamimidoilbenzamido]propil}-1-{2,4-dicloro-3-[(2,4-dimetilquinolein-8-iloxi]metill]fenil]sulfonil}pirrolidina-2-carboxamida

C₃₄H₃₆Cl₂N₆O₅S

ardenerminum

ardenermin

B-lymphocte stimulator-(134-285)-peptide

ardénermine

peptide-(134-285)-stimulateur du lymphocyte-B humain

ardenermina

péptido-(134-285)-estimulante del linfocito-B humano

[C₇₇₀H₁₂₀₅N₁₉₃O₂₃₂S₅]₆

arimoclomolum

arimoclomol

N-[(2R)-2-hydroxy-3-(1-piperidyl)propoxy]pyridine-3-carboximidoyl chloride, 1-oxide

arimoclomol

1-oxyde du chlorure de N-[(2R)-2-hydroxy-3-(pipéridin-1-yl)propoxy]pyridin-3-carboximidoyle

arimoclomol

1-óxido del cloruro de (Z)-N-[(2R)-2-hidroxi-3-(1-piperidil)propoxi]piridina-3-carboximidoilo

C₁₄H₂₀ClN₃O₃

aselizumabum

aselizumab

immunoglobulin G4, anti-(L-selectin) (human-mouse monoclonal

HuDreg-55 heavy chain), disulfide with human-mouse monoclonal HuDreg-55 light chain, dimer

asélizumab

immunoglobuline G4, anti-(sélectine L) (chaîne lourde de l'anticorps monoclonal de souris HuDreg-55 humanisé), dimère du disulfure avec la chaîne légère de l'anticorps monoclonal de souris HuDreg-55 humanisé

aselizumab

inmunoglobulina G4, anti-(selectina L) (cadena pesada del anticuerpo monoclonal humanizado de ratón HuDreg-55), dímero del disulfuro con la cadena ligera del anticuerpo monoclonal humanizado de ratón HuDreg-55

asoprisnili ecamas

asoprisnil ecamate

11β-{4-[(E)-(ethylcarbamoyloxyimino)methyl]phenyl}-17β-methoxy-17α-(methoxymethyl)estra-4,9-dien-3-one

écamate d'asoprisnil

11β-[4-[(E)-[[(éthylcarbamoyl)oxy]imino]méthyl]phényl]-17β-méthoxy-17-(méthoxyméthyl)estra-4,9-dién-3-one

ecamato de asoprisnilo

11β-{4-[(E)-[[(etilcarbamoil)oxi]imino]metil]fenil}-17β-metoxi-17α-(metoximetil)estra-4,9-dien-3-ona

C₃₁H₄₀N₂O₅

ataciguatum

ataciguat

5-chloro-2-[(5-chloro-2-thienyl)sulfonylamino]-N-[4-(morpholin-4-ylsulfonyl)phenyl]benzamide

ataciguat

5-chloro-2-[[(5-chlorothiophén-2-yl)sulfonyl]amino]-N-[4-(morpholin-4-ylsulfonyl)phényl]benzamide

ataciguat

5-cloro-2-[(5-cloro-2-tienil)sulfonilamino]-N-[4-(morfolin-4-ilsulfonil)fenil]benzamida

C₂₁H₁₉Cl₂N₃O₆S₃

atazanavirum

atazanavir

dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13- pentaazatetradecanedioate

atazanavir

(3S,8S,9S,12S)-9-benzyl-3,12-bis(1,1-diméthyléthyl)-8-hydroxy-4,11-dioxo-6-[4-(pyridin-2-yl)benzyl]-2,5,6,10,13- pentaazatétradécanedioate de diméthyle

atazanavir

(3S,8S,9S,12S)-9-bencil-3,12-di-terc-butil-8-hidroxi-4,11-dioxo-6-[4-(2-piridill)bencil]-2,5,6,10,13-pentaazatetradecanodioato de dimetilo

C₃₈H₅₂N₆O₇

barixibatum

barixibat

11-(D-gluconamido)-N-{2-[(1S,2R,3S)-3-hydroxy-3-phenyl-2-(2-pyridyl)-1-(2-pyridylamino)propyl]phenyl}undecanamide

barixibat

11-(D-gluconylamino)-N-[2-[(1S,2R,3S)-3-hydroxy-3-phényl-2-(pyridin-2-yl)-1-(pyridin-2-ylamino)propyl]phényl]undécanamide

barixibat

{N-[2-[(1S,2R,3S)-3-fenil-3-hidroxi-2-(piridin-2-il)-1-(piridin-2-ilamino)propil]fenil]-11-(D-gluconamido)}undecanamida

C₄₂H₅₅N₅O₈

barusibanum

barusiban

C^4.6,S¹-cyclo[N-(3-sulfanylpropanoyl)-D-tryptophyl-L-isoleucyl-L-alloisoleucyl-L-asparaginyl-L-2-aminobutanoyl-N-methyl-L-ornithinol]

barusiban

(4S,7S,10S,13S,16R)-N-[(1S)-4-amino-1-(hydroxyméthyl)butyl]-7-(2-amino-2-oxoéthyl)-16-(1H-indol-3-ylméthyl)-N-méthyl-10-[(1R)- 1-méthylpropyl]-13-[(1S)-1-méthylpropyl]-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide

barusibán

C^4.6,S¹-ciclo[N-(3-sulfanilpropanoil)-D-triptofil-L-isoleucil-L-aloisoleucil-L-asparaginil-L-2-aminobutanoil-N-metil-L-ornitinol

C₄₀H₆₃N₉O₈S

bertilimumabum

bertilimumab

immunoglobulin G4, anti-(human eotaxin 1) (human monoclonal CAT-213 γ4-chain), disulfide with human monoclonal CAT-213κ-chain, dimer

bertilimumab

immunoglobuline G4, anti-(éotaxine 1 humaine) (chaîne γ4 de l'anticorps monoclonal humain CAT-213), dimère du disulfure avec la chaîne κde l'anticorps monoclonal humain CAT-213

bertilimumab

inmunoglobulina G4, anti-(eotaxina 1 humana) (cadena γ4 del anticuerpo monoclonal humano CAT-213), dímero del disulfuro con la cadena κdel anticuerpo monoclonal humano CAT-213

bortezomibum

bortezomib

{(1R)-3-methyl-1-[(2S)-3-phenyl-2-(pyrazin-2-carboxamido)= propanamido]butyl}boronic acid

bortézomib

acide [(1R)-3-méthyl-1-[[(2S)-3-phényl-2-[(pyrazinylcarbonyl)amino]= propanoyl]amino]butyl]boronique

bortezomib

ácido {(1R)-3-metil-1-[(2S)-3-fenil-2(pirazin-2-carboxamido)= propanamido]butil}borónico

C₁₉H₂₅BN₄O₄

cinacalcetum

cinacalcet

N-[(1R)-1-(1-naphthyl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine

cinacalcet

N-[(1R)-1-(naphtalén-1-yl)éthyl]-3-[3-(trifluorométhyl)phényl]propan-1-amine

cinacalcet

N-[(1R)-1-(1-naftil)etil]-3-[3-(trifluorometil)fenil]propan-1-amina

C₂₂H₂₂F₃N

darunavirum

darunavir

(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(1S,2R)-1-benzyl-2-hydroxy-3-(N¹-isobutylsulfanilamido)propyl]carbamate

darunavir

[(1S,2R)-3-[[(4-aminophényl)sulfonyl](2-méthylpropyl)amino]-1-benzyl-2-hydroxypropyl]carbamate de (3R,3aS,6aR)- hexahydrofuro[2,3-b]furan-3-yle

darunavir

N-[(1S,2R)-1-bencil-2-hidroxi-3-(N-isobutilsulfanilamido)propil]= carbamato de (3R,3aS,6aR)-hexahidrofuro[2,3-b]furan-3-ilo

C₂₇H₃₇N₃O₇S

dexmethylphenidatum

dexmethylphenidate

methyl (2R)-phenyl[(2R)-2-piperidyl]acetate

dexméthylphénidate

(2R)-phényl[(2R)-pipéridin-2-yl]acétate de méthyle

dexmetilfenidato

(2R)-fenil[(2R)-2-piperidiil]acetato de metilo

C₁₄H₁₉NO₂

disufentonum natricum

disufenton sodium

disodium 4-(tert-butyliminomethyl)benzene-1,3-disulfonate N-oxide

disufenton sodique

N-oxyde de 4-[[(1,1-diméthyléthyl)imino]méthyl]benzène-1,3-disulfonate de disodium

disufentón de sodio

N-óxido de 4-terc-butiliminometil]benceno-1,3-disulfonato de disodio

C₁₁H₁₃NNa₂O₇S₂

dofequidarum

dofequidar

1-(diphenylacetyl)-4-[(2RS)-2-hydroxy-3-(5-quinolyloxy)propyl]piperazine

doféquidar

1-(diphénylacétyl)-4-[(2RS)-2-hydroxy-3-(quinoléin-5-yloxy)propyl]pipérazine

dofequidar

1-(difenilacetil)-4-[(2RS)-2-hidroxi-3-(quinolein-5-iloxi)propil]piperazina

C₃₀H₃₁N₃O₃

doramapimodum

doramapimod

1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea

doramapimod

1-[3-(1,1-diméthyléthyl)-1-(4-méthylphényl)-1H-pyrazol-5-yl]-3-[4-[2-(morpholin-4-yl)éthoxy]naphtalén-1-yl]urée

doramapimod

1-[3-terc-butil-1-(4-metilfenil)-1H-pirazol-5-il]-3-[4-(2-morfolinoetoxi)-1-naftil]urea

C₃₁H₃₇N₅O₃

etiprednoli dicloacetas

etiprednol dicloacetate

ethyl 17α-(dichloroacetoxy)-11β-hydroxy-3-oxoandrosta-1,4-diene-17β-carboxylate

dicloacétate d'étiprednol

17-[(dichloroacétyl)oxy]-11β-hydroxy-3-oxoandrosta-1,4-diène-17β-carboxylate d'éthyle

dicloroacetato de etiprednol

17-[(dicloroacetil)oxi]-11β-hidroxi-3-oxoandrosta-1,4-dieno-17β-carboxilato de etilo

C₂₄H₃₀Cl₂O₆

etravirinum

etravirine

4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy]-3,5-dimethylbenzonitrile

étravirine

4-[[6-amino-5-bromo-2-[(4-cyanophényl)amino]pyrimidin-4-yl]oxy]-3,5-diméthylbenzonitrile

etravirina

4-[6-amino-5-bromo-2-(4-cianoanilino)pirimidin-4-iloxi]-3,5-dimetilbenzonitrilo

C₂₀H₁₅BrN₆O

etriciguatum

etriciguat

2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(4-pyridyl)pyrimidin-4-amine

étriciguat

2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(pyridin-4-yl)pyrimidin-4-amine

etriciguat

2-[1-(2-fluorobencil)-1H-pirazolo[3,4-b]piridin-3-il]-5-(4-piridil)pirimidin-4-amina

C₂₂H₁₆FN₇

fipamezolum

fipamezole

4-[(2RS)-2-ethyl-5-fluoroindan-2-yl]-1H-imidazole

fipamézole

4-[(2RS)-2-éthyl-5-fluoro-2,3-dihydro-1H-indén-2-yl]-1H-imidazole

fipamezol

4-[(2RS)-2-etil-5-fluoroindan-2-il]-1H-imidazol

C₁₄H₁₅FN₂

gemcabenum

gemcabene

2,2,2',2'-tetramethyl-6,6'-oxydihexanoic acid

gemcabène

acide 6,6'-oxybis(2,2-diméthylhexanoïque)

gemcabeno

ácido 2,2,2',2'-tetrametil-6,6'-dihexanoico

C₁₆H₃₀O₅

ibrolipimum

ibrolipim

diethyl {4-[(4-bromo-2-cyanophenyl)carbamoyl]benzyl}phosphonate

ibrolipim

[4-[(4-bromo-2-cyanophényl)carbamoyl]benzyl]phosphonate de diéthyle

ibrolipim

[4-[(4-bromo-2-cianofenil)carbamoil]bencil]fosfonato de dietilo

C₁₉H₂₀BrN₂O₄P

iclaprimum

iclaprim

5-[(2RS)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-ylmethyl]pyrimidine-2,4-diamine

iclaprime

5-[[(2RS)-2-cyclopropyl-7,8-diméthoxy-2H-1-benzopyran-5-yl]methyl]pyrimidine-2,4-diamine

iclaprim

5-[(2RS)-2-ciclopropil-7,8-dimetoxi-2H-cromen-5-ilmetil]pirimidina-2,4-diamina

C₁₉H₂₂N₄O₃

iosimenolum

iosimenol

5,5'-[propanedioylbis[(2,3-dihydroxypropyl)imino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide]

iosiménol

5,5'-[propanedioylbis[(2,3-dihydroxypropyl)imino]bis[N-(2,3-dihydroxypropyl)-2,4,6-triiodobenzène-1,3-dicarboxamide]

iosimenol

5,5'-[propanodioilbis[(2,3-dihidroxipropil)imino]bis[N-(2,3-dihidroxipropil)-2,4,6-triiodobenceno-1,3-dicarboxamida]

C₃₁H₃₆I₆N₆O₁₄

latidectinum

latidectin

mixture of components A₄ and A₃
component A₄
(2a¹S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR)-6'-ethyl-2a¹,20-dihydroxy-5',6,8,19-tetramethyl-17-oxo-2a¹,3',4',5',6,6',7,10,11,14,15,17a,20,20a-tetradecahydro-2H,13H,17H-spiro[11,15-methanofuro[4,3,2- pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 1-[4-(methoxyacetamido)phenyl]cyclopentanecarboxylate
component A₃
(2a¹S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR)-2a¹,20-dihydroxy-5',6,6',8,19-pentamethyl-17-oxo-2a¹,3',4',5',6,6',7,10,11,14,15,17a,20,20a-tetradecahydro-2H,13H,17H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-[2H]pyran]-7-yl 1-[4-(methoxyacetamido)phenyl]cyclopentanecarboxylate

latidectine

mélange des composés A₄ et A₃
composé A₄
1-[4-[(méthoxyacétyl)amino]phényl]cyclopentanecarboxylate de(2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-éthyl-20,20b-dihydroxy-5',6,8,19-tétraméthyl-17-oxo-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tétradécahydrospiro[11,15-méthano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadécine-13,2'-[2H]pyran]-7-yle
composé A₃
1-[4-[(méthoxyacétyl)amino]phényl]cyclopentanecarboxylate de(2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,6',8,19-tétraméthyl-17-oxo-3',4',5',6,6',7,10,11,14,15,17a,20,20a,20b-tétradécahydrospiro[11,15-méthano-2H,13H,17H-furo[4,3,2-pq][2,6]benzodioxacyclooctadécine-13,2'-[2H]pyran]-7-yle

latidectina

mezcla de los componentes A₄ y A₃
componente A₄
1-[4-[(metoxiacetamido]fenil]ciclopentanocarboxilato de(2a¹S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR), -6'-etil-2a¹,20-dihidroxi-5',6,8,19-tetrametil-17-oxo-2a¹,3',4',5',6,6',7,10,11,14,15,17a,20,20a, -tetradecahidro-2H,13H,17H-spiro[11,15-metanofuro[4,3,2-pq][2,6]benzodioxaciclooctadecino-13,2'-[2H]piran]-7-ilo
componente A₃
1-[4-[metoxiacetamido]fenil]ciclopentanocarboxilato de(2a¹S,2aE,4E,5'S,6S,6'R,7R,8E,11R,13R,15S,17aR,20R,20aR,)-2a¹,20,-dihidroxi-5',6,6',8,19-pentametil-17-oxo-2a¹,3',4',5',6,6',7,10,11,14,15,17a,20,20a,-tetradecahidro-2H,13H,17H-spiro[11,15-metano-furo[4,3,2-pq][2,6]benzodioxaciclooctadecino-13,2'-[2H]piran]-7-ilo

C₄₆H₆₁NO₁₁ (component A₃)
C₄₇H₆₃NO₁₁ (component A₄)

lurasidonum

lurasidone

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione

lurasidone

(3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)pipérazin-1-yl]méthyl]cyclohexyl]méthyl]hexahydro-4,7-méthano-2H-isoindole-1,3-dione

lurasidona

3aR,4S,7R,7aS)-2-[[(1R,2R)-2-[[4-(1,2-bencisotiazol-3-il)piperazin-1-il]metil]ciclohexil]metil]hexahidro-4,7-metano-2H-isoindol-1,3-diona

C₂₈H₃₆N₄O₂S

mantabegronum

mantabegron

(2RS)-1-(adamantan-1-ylamino)-3-phenoxypropan-2-ol

mantabégron

(2RS)-1-phénoxy-3-(tricyclo[3.3.1.1^3,7]déc-1-ylamino)propan-2-ol

mantabegrón

(2RS)-1-fenoxi-3-(triciclo[3.3.1.1^3,7]dec-1-ilamino)propan-2-ol

C₁₉H₂₇NO₂

matuzumabum

matuzumab

immunoglobulin G1, anti-(human epidermal growth factor receptor) (humanized MAb 425 γ1 chain), disulfide with humanized MAb 425 κ-chain, dimer

matuzumab

immunoglobuline G1, anti-(récepteur du facteur de croissance humain de l'épiderme) (chaîne γ1 de l'anticorps monoclonal de souris 425 humanisé), dimère du disulfure avec la chaîne κ de l'anticorps monoclonal de souris 425 humanisé

matuzumab

inmunoglobulina G1, anti-(receptor humano del factor de crecimiento de la epidermis) (cadena γ1 del anticuerpo monoclonal humanizado de ratón 425), dímero del disulfuro con la cadena κdel anticuerpo monoclonal humanizado de ratón 425

meclinertantum

meclinertant

2-[[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl]amino]tricyclo[3.3.1.1^3,7]decane-2-carboxylic acid

méclinertant

acide 2-[[[1-(7-chloroquinoléin-4-yl)-5-(2,6-diméthoxyphényl)- 1H-pyrazol-3-yl]carbonyl]amino]tricyclo[3.3.1.1^3,7]décane-2-carboxylique

meclinertant

ácido 2-[[[1-(7-cloroquinolin-4-il)-5-(2,6-dimetoxifenil)-1H-pirazol-3-il]carbonil]amino]triciclo[3.3.1.1^3,7]decano-2-carboxílico

C₃₂H₃₁ClN₄O₅

mitratapidum

mitratapide

2-[(2R)-butan-2-yl]-4-(4-{4-[4-({(2S,4R)-2-(4-chlorophenyl)-2-[(4-methyl-4H-1,2,4-triazol-3-ylsulfanyl)methyl]-1,3-dioxolan-4-yl}methoxy)phenyl]piperazin-1-yl}phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one

mitratapide

4-[4-[4-[4-[[(2S,4R)-2-(4-chlorophényl)-2-[[(4-méthyl-4H-1,2,4-triazol-3-yl)sulfanyl]méthyl]-1,3-dioxolan-4-yl]méthoxy]phényl]pipérazin-1-yl]phényl]-2-[(1R)-1-méthylpropyl]-2,4-dihydro-3H-1,2,4-triazol-3-one

mitratapida

2-[(2R)-butan-2-il]-4-(4-{4-[4-({2-(4-clorofenil)-2-[(2S,4R)-(4-metil-4H-1,2,4-triazol-3-ilsulfanil)metil]-1,3-ioxolan-4-il}metoxi)= fenil]piperazin-1-il}fenil)-2,4-dihidro-3H-1,2,4-triazol-3-ona

C₃₆H₄₁ClN₈O₄S

oxeglitazarum

oxeglitazar

(2E,4E)-5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methylpenta-2,4-dienoic acid

oxéglitazar

acide (2E,4E)-5-(7-méthoxy-3,3-diméthyl-2,3-dihydro-1-benzoxépin-5-yl)-3-méthylpenta-2,4-diénoïque

oxeglitazar

ácido (2E,4E)-3-metil-5-(3,3-dimetil-7-metoxi-2,3-dihidro-1-benzoxepin-5-il)penta-2,4-dienoico

C₁₉H₂₂O₄

posizolidum

posizolid

(5R)-3-(4-{1-[(2S)-2,3-dihydroxypropanoyl]-1,2,3,6-tetrahydro-4-pyridyl}-3,5-difluorophenyl)-5-(1,2-oxazol-3-yloxymethyl)-1,3-oxazolidin-2-one

posizolid

(5R)-3-[4-[1-[(2S)-2,3-dihydroxypropanoyl]-1,2,3,6-tétrahydropyridin-4-yl]-3,5-difluorophényl]-5-[(isoxazol-3-yloxy)méthyl]oxazolidin-2-one

posizolid

(5R)-3-(4-{1-[(2S)-2,3-dihidroxipropanoil]-1,2,3,6-tetrahidro-4-piridil}-3,5-difluorofenil)-5-[(isoxazol-3-iloxi)metil]oxazolidin-2-ona

C₂₁H₂₁F₂N₃O₇

rafabegronum

rafabegron

(3-{(2R)-2-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino]propyl}-1H-indol-7-yloxy)acetic acid

rafabégron

acide [[3-[(2R)-2-[[(2R)-2-(3-chlorophényl)-2-hydroxyéthyl]= amino]propyl]-1H-indol-7-yl]oxy]acétique

rafabegrón

ácido (3-{(2R)-2-[(2R)-2-(3-clorofenil)-2-hidroxetilamino]propil}-1H-indol-7-iloxi)acético

C₂₁H₂₃ClN₂O₄

rupintrivirum

rupintrivir

ethyl (2E,4S)-4-[(2R,5S)-2-(4-fluorobenzyl)-6-methyl-5-(5-methyl-1,2-oxazol-3-carboxamido)-4-oxoheptanamido]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-enoate

rupintrivir

(2E,4S)-4-[[(2R,5S)-2-(4-fluorobenzyl)-6-méthyl-5-[[(5-méthylisoxazol-3-yl)carbonyl]amino]-4-oxoheptanoyl]amino]-5-[(3S)-2-oxopyrrolidin-3-yl]pent-2-énoate d'éthyle

rupintrivir

(2E,4S)-4-[(2R,5S)-2-(4-fluorobencil)-6-metil-5-(5-metil-1,2-isoxazol-3-carboxamido)-4-oxoheptanamido]-5-[(3S)-2-oxopirrolidin-3-il]pent-2-enoato de etilo

C₃₁H₃₉FN₄O₇

sorafenibum

sorafenib

4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N²-methylpyridine-2-carboxamide

sorafénib

4-[4-[[[4-chloro-3-(trifluorométhyl)phényl]carbamoyl]amino]phénoxy]-N-méthylpyridine-2-carboxamide

sorafenib

4-(4-{3-[4-cloro-3-(trifluorometil)fenil]ureido}fenoxi)-N²-metilpiridina-2-carboxamida

C₂₁H₁₆ClF₃N₄O₃

squalaminum

squalamine

(24R)-3β-[3-(4-aminobutylamino)propylamino]-7α-hydroxy-5α-cholestan-24-yl hydrogen sulfate

squalamine

hydrogénosulfate de (24R)-3β-[[3-[(4-aminobutyl)amino]= propyl]amino]-7α-hydroxy-5α-cholestan-24-yle

escualamina

hidrógenosulfato de (24RS)-3β-[3-(4-aminobutilamino)propilamino]-7α-hidroxi-5α-colestan-24-ilo

C₃₄H₆₅N₃O₅S

tacedinalinum

tacedinaline

4-acetamido-N-(2-aminophenyl)benzamide

tacédinaline

4-(acétylamino)-N-(2-aminophényl)benzamide

tacedinalina

4-acetamido-N-(2-aminofenil)benzamida

C₁₅H₁₅N₃O₂

telbivudinum

telbivudine

1-(2-deoxy-β-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione

telbivudine

1-(2-désoxy-β-L-érythro-pentofuranosyl)-5-méthylpyrimidine-2,4(1H,3H)-dione

telbivudina

1-(2-desoxi-β-L-eritro-pentofuranosil)-5-metilpirimidina-2,4(1H,3H)-diona

C₁₀H₁₄N₂O₅

tolevamerum

tolevamer

poly[1-(4-sulfophenyl)ethylene]

tolévamer

poly[1-(4-sulfophényl)éthylène]

tolevámero

poli[1-(4-sulfofenil)etileno]

(C₈H₈O₃S)_n

p. 58

lurasidonum

lurasidone

replace the chemical name by the following:

(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione

p. 60

delete/supprimer/suprimase

insert/insérer/insértese

mitratapidum

mitratapidum

mitratapid

mitratapide

mitratapid

mitratapide

mitratapid

mitratapida

p. 118

axomadolum

axomadol

replace the molecular formula by the following:

axomadol

remplacer la formule brute par:

axomadol

sustitúyase la fórmula molecular por:

C₁₆H₂₅NO₃

Procedure and Guiding Principles/Procédure et Directives/Procedimientos y principios generales

The text of the Procedures for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances and General Principles for Guidance in Devising International Nonproprietary Names for Pharmaceutical Substances will be reproduced in uneven numbers of proposed INN lists only.

Les textes de la Procédure à suivre en vue du choix de dénominations communes internationales recommandées pour les substances pharmaceutiques et des Directives générales pour la formation de dénominations communes internationales applicables aux substances pharmaceutiques seront publiés seulement dans les numéros impairs des listes des DCIs proposées.

El texto de los Procedimientos de selección de denominaciones comunes internacionales recomendadas para las sustancias farmacéuticas y de los Principios generales de orientación para formar denominaciones comunes internacionales para sustancias farmacéuticas aparece solamente en los números impares de las listas de DCI propuestas.